Pharming Group N.V.PHARNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank43
5Y CAGR+24.5%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
+24.5%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 13.39% |
| 2023 | 27.08% |
| 2022 | 43.07% |
| 2021 | -25.96% |
| 2020 | 16.32% |
| 2019 | 4.47% |
| 2018 | 19.22% |
| 2017 | 455.67% |
| 2016 | 52.93% |
| 2015 | 30.62% |